Home / MissionIR Articles

MissionIR Articles

  • DARA BioSciences (DARA) Presents at Rodman & Renshaw Conference

    DARA BioSciences, Inc. (NASDAQ: DARA) is an oncology supportive care pharmaceutical company dedicated to providing healthcare professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects arising…

  • CytRx (CYTR) Presents at Rodman & Renshaw Conference

    CytRx Corporation (NASDAQ: CYTR) is a biopharmaceutical research and development company specializing in oncology. CytRx is focused on the clinical development of aldoxorubicin (formerly known as INNO-206), its improved version of the widely used chemotherapeutic…

  • CytoSorbents (CTSO) Presents at Rodman & Renshaw Conference

    CytoSorbents Corp. (NASDAQ: CTSO) is a critical care immunotherapy company using blood purification to treat life-threatening illnesses. The company has developed a new hemoperfusion technology for removing toxins from the blood associated with sepsis, kidney…

  • CytoDyn (CYDY) Presents at Rodman & Renshaw Conference

    CytoDyn, Inc. (OTCQB: CYDY) is focused on developing new therapies that provide flexibility and freedom to people across the globe who are living with HIV. The company’s lead product, PRO 140, belongs to a new…

  • Cynapsus Therapeutics (CYNA) Presents at Rodman & Renshaw Conference

    Cynapsus Therapeutics, Inc. (NASDAQ: CYNA)  is a specialty central nervous system pharmaceutical company developing and preparing to commercialize a fast-acting, easy-to-use, sublingual thin film for the on-demand turning ON of debilitating OFF episodes associated with…

  • Cymabay Therapeutics (CBAY) Presents at Rodman & Renshaw Conference

    Cymabay Therapeutics, Inc. (NASDAQ: CBAY) is a clinical-stage biopharmaceutical company located in the San Francisco Bay Area focused on developing therapies to treat metabolic diseases with high unmet medical need or serious rare and orphan…

  • Cyclacel Pharmaceuticals (CYCC) Presents at Rodman & Renshaw Conference

    Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) is a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases. Professor Sir David Lane, a…

  • Critical Outcome Technologies (COTQF) Presents at Rodman & Renshaw Conference

    Critical Outcome Technologies, Inc. (OTC: COTQF) is engaged in disease-specific drug discovery, optimization and pre-clinical development using a specially developed series of computer models. COTI is focused on the discovery and pre-clinical development of small…

  • Cortex Pharmaceuticals (CORX) Presents at Rodman & Renshaw Conference

    Cortex Pharmaceuticals, Inc. (OTC: CORX) has multiple drug development programs targeted toward the treatment of brain-related breathing disorders, such as obstructive or central sleep apnea and drug-induced respiratory depression. One key program involves the development…

  • CorMedix (CRMD) Presents at Rodman & Renshaw Conference

    CorMedix, Inc. (NYSE: CRMD) is a commercial-stage biopharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases. CorMedix’s first commercial product in Europe…

  • ContraVir Pharmaceuticals (CTRV) Presents at Rodman & Renshaw Conference

    ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) operates as a biopharmaceutical company focused on developing targeted antiviral therapies. The company has two drug candidates in clinical studies. The first, FV-100, is now in phase III trials and…

  • CombiMatrix (CBMX) Presents at Rodman & Renshaw Conference

    CombiMatrix Corp. (NASDAQ: CBMX) is a clinical diagnostic laboratory specializing in cytogenomic testing for prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. As a full-scale cytogenetic and cytogenomic laboratory, CombiMatrix offers chromosomal microarray analysis, standard…

  • CoLucid Pharmaceuticals (CLCD) Presents at Rodman & Renshaw Conference

    Founded in 2005, biopharmaceutical company CoLucid Pharmaceuticals, Inc. (NASDAQ: CLCD) is focused on developing small molecules for the acute treatment of migraine headaches. The company’s lead product candidates are oral lasmiditan, an oral tablet for…

  • Codexis (CDXS) Presents at Rodman & Renshaw Conference

    Codexis, Inc. (NASDAQ: CDXS) provides unique, state-of-the-art enzyme optimization services and developing biocatalyst products. The company’s technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients (APIs), fine chemicals, agrochemicals, food ingredients, detergents and…

  • Clean Diesel Technologies (CDTI) Presents at Rodman & Renshaw Conference

    Clean Diesel Technologies, Inc. (NASDAQ: CDTI) is a cleantech emissions control company that designs, develops and manufactures sustainable solutions to reduce emissions of on- and off-road engine applications. Within its sector, the company is a…

  • Cipher Pharmaceuticals (CPHR) Presents at Rodman & Renshaw Conference

    Cipher Pharmaceuticals, Inc. (NASDAQ: CPHR) is a dermatology company committed to offering healthcare professionals products that will better address their patients’ needs and enrich their practices. As such, the company’s innovative dermatology products provide efficacy,…

  • China XD Plastics Company (CXDC) Presents at Rodman & Renshaw Conference

    China XD Plastics Company Ltd. (NASDAQ: CXDC) engages in researching, developing, manufacturing and selling modified plastics primarily for automotive applications in China and Dubai, the United Arab Emirates. The company’s modified plastics are used to…

  • China Recycling Energy (CREG) Presents at Rodman & Renshaw Conference

    China Recycling Energy Corp. (NASDAQ: CREG) designs, finances, constructs, operates and transfers waste energy recycling projects to mid- to large-size enterprises involved in high energy-consuming businesses. The company offers waste pressure to energy systems, including…

  • China Jo-Jo Drugstores (CJJD) Presents at Rodman & Renshaw Conference

    China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD), through its own retail drugstores, wholesale distributor and online pharmacy, is a retailer and wholesale distributor of pharmaceutical and healthcare products in China. As of March 31, 2015, the…

  • China Energy Technology (CETH) Presents at Rodman & Renshaw Conference

    China Energy Technology Corp., Ltd. (OTC: CETH) designs, manufactures, and sells solar water heaters and related solar products. The company offers vacuum tube solar energy collector, as well as the balcony flat panel solar energy…

  • ChemoCentryx (CCXI) Presents at Rodman & Renshaw Conference

    ChemoCentryx, Inc. (NASDAQ: CCXI) is a biopharmaceutical company that specializes in creating orally administered new medicines that inhibit chemo-attractant receptors – the engines of cell migration in disease. The company focuses exclusively on discovering, developing…

  • Chembio Diagnostics (CEMI) Presents at Rodman & Renshaw Conference

    Chembio Diagnostics, Inc. (NASDAQ: CEMI) is committed to delivering exceptional products that provide ease of use, and rapid and accurate results at the point-of-care (POC). At the core of its commitment is its patented Next…

  • Check-Cap (CHEK) Presents at Rodman & Renshaw Conference

    Check-Cap Ltd. (NASDAQ: CHEK) is a clinical stage medical diagnostics company leading the development of the first ingestible imaging capsule that utilizes low-dose X-rays for CRC screening. The Check-Cap device requires no bowel preparation or…

  • Cesca Therapeutics (KOOL) Presents at Rodman & Renshaw Conference

    Cesca Therapeutics Inc. (NASDAQ: KOOL) is focused on three target markets: cellular therapeutics; medical/diagnostic device development and commercialization; and cell manufacturing and banking. Cesca’s lead therapeutic technology platform, SurgWerks (an intraoperative rapid system for harvesting,…

  • Cerulean Pharma (CERU) Presents at Rodman & Renshaw Conference

    Cerulean Pharma, Inc. (NASDAQ: CERU) is focused on making nanoparticle-drug conjugates (NDCs) designed to target rumors, reduce toxicity and enable combinations. The Cerulean team is committed to developing products to improve treatment options for people…

  • Celsion (CLSN) Presents at Rodman & Renshaw Conference

    Celsion Corporation (NASDAQ: CLSN), a fully-integrated oncology company, is focused on developing a portfolio of cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA-based therapies. The company’s lead program is ThermoDox, a proprietary heat-activated…

  • Cellectar Biosciences (CLRB) Presents at Rodman & Renshaw Conference

    Cellectar Biosciences, Inc. (NASDAQ: CLRB) is developing agents to detect, treat and monitor a broad spectrum of cancers. With the ability to attach imaging and therapeutic agents to its proprietary delivery platform – a novel…

  • Celator Pharmaceuticals (CPXX) Presents at Rodman & Renshaw Conference

    Celator Pharmaceuticals, Inc. (NASDAQ: CPXX) is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve patient outcomes in cancer. Celator’s proprietary technology platform, CombiPlex, enables the rational…

  • Catalyst Pharmaceuticals (CPRX) Presents at Rodman & Renshaw Conference

    Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases. Catalyst is developing Firdapse (Amifampridine Phosphate, or 3,4-diaminopyridine phosphate) for the treatment of…

  • Catalyst Biosciences (CBIO) Presents at Rodman & Renshaw Conference

    Catalyst Biosciences, Inc. (NASDAQ: CBIO) is a clinical-stage biopharmaceutical company focused on creating and developing novel medicines to address serious medical conditions in the fields of hemostasis. Catalyst’s most advanced program, an improved next-generation coagulation…

  • CASI Pharmaceuticals (CASI) Presents at Rodman & Renshaw Conference

    CASI Pharmaceuticals, Inc. (NASDAQ: CASI) is a biopharmaceutical company focused on the acquisition, development, and commercialization of therapeutics addressing cancer and other unmet medical needs. Part of its strategy is to leverage its expertise and…

  • Cardiome Pharma (CRME) Presents at Rodman & Renshaw Conference

    Cardiome Pharma Corp. (NASDAQ: CRME) is an integrated, commercial, specialty pharmaceutical company dedicated to the development and commercialization of new therapies that will improve the health and quality of life of patients. The company strives…

  • Capstone Turbine (CPST) Presents at Rodman & Renshaw Conference

    Capstone Turbine Corporation (NASDAQ: CPST) is the world’s leading developer and manufacturer of clean-and-green microturbine power generation systems, and was first to market with its high efficiency air bearing turbine technology. Capstone has shipped thousands…

  • Capstone Therapeutics (CAPS) Presents at Rodman & Renshaw Conference

    Capstone Therapeutics Corp. (OTC: CAPS) is a biotechnology company committed to developing a pipeline of novel peptides and other molecules aimed at helping patients with underserved medical conditions. Its primary asset is ownership in a…

  • Capricor Therapeutics (CAPR) Presents at Rodman & Renshaw Conference

    Capricor Therapeutics, Inc. (NASDAQ: CAPR)is focused on discovering, developing and marketing first-in-class therapeutics for the treatment of diseases. Presently, the company is positioned at the forefront of one of the largest segments of the U.S.…

  • Capnia (CAPN) Presents at Rodman & Renshaw Conference

    Capnia, Inc. (NASDAQ: CAPN) develops diagnostic and therapeutic products based on its proprietary technology for the precision metering of gas flow. Operating primarily in the U.S., the company offers CoSense for the diagnosis of excessive…

  • Can-FiteBioPharma (CANF) Presents at Rodman & Renshaw Conference

    Can-FiteBioPharma Ltd. (NYSE: CANF) is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The company has an advanced pipeline of proprietary compounds in phase II and III clinical development stage,…

  • Cadiz (CDZI) Presents at Rodman & Renshaw Conference

    Founded more than 25 years ago, Cadiz Inc. (NASDAQ: CDZI) is a Los Angeles-based renewable resource company dedicated to pursuing sustainable projects through the responsible stewardship of its land and water resources. The company owns…

  • Matinas BioPharma Holdings, Inc. (MTNB) Utilizing Proprietary Technology to Improve Safety Profile of Existing Drugs

    Matinas Biopharma Holdings is a clinical-stage biopharmaceutical company focused on the development of safe and effective broad spectrum antifungal and anti-bacterial therapeutics for the treatment of serious and life-threatening infections. The company’s proprietary, disruptive technology…

  • Brainstorm Cell Therapeutics (BCLI) Presents at Rodman & Renshaw Conference

    Brainstorm Cell Therapeutics, Inc. (NASDAQ: BCLI)is developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases, e.g. Amyotrophic Lateral Sclerosis (ALS a.k.a. Lou Gehrig’s disease), Multiple Sclerosis (MS) and Parkinson’s disease (PD). NurOwn is…